Q9 |
1 class b & 2 class c fndngs |
One class b and two class c findings |
Q9001 |
Chaplain assessment |
Assessment by chaplain services |
Q9002 |
Chaplain counsel individu |
Counseling, individual, by chaplain services |
Q9003 |
Chaplain counsel group |
Counseling, group, by chaplain services |
Q9004 |
Va whole health partner serv |
Department of veterans affairs whole health partner services |
Q9950 |
Inj sulf hexa lipid microsph |
Injection, sulfur hexafluoride lipid microspheres, per ml |
Q9951 |
Locm >= 400 mg/ml iodine,1ml |
Low osmolar contrast material, 400 or greater mg/ml iodine concentration, per ml |
Q9953 |
Inj fe-based mr contrast,1ml |
Injection, iron-based magnetic resonance contrast agent, per ml |
Q9954 |
Oral mr contrast, 100 ml |
Oral magnetic resonance contrast agent, per 100 ml |
Q9955 |
Inj perflexane lip micros,ml |
Injection, perflexane lipid microspheres, per ml |
Q9956 |
Inj octafluoropropane mic,ml |
Injection, octafluoropropane microspheres, per ml |
Q9957 |
Inj perflutren lip micros,ml |
Injection, perflutren lipid microspheres, per ml |
Q9958 |
Hocm <=149 mg/ml iodine, 1ml |
High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml |
Q9959 |
Hocm 150-199mg/ml iodine,1ml |
High osmolar contrast material, 150-199 mg/ml iodine concentration, per ml |
Q9960 |
Hocm 200-249mg/ml iodine,1ml |
High osmolar contrast material, 200-249 mg/ml iodine concentration, per ml |
Q9961 |
Hocm 250-299mg/ml iodine,1ml |
High osmolar contrast material, 250-299 mg/ml iodine concentration, per ml |
Q9962 |
Hocm 300-349mg/ml iodine,1ml |
High osmolar contrast material, 300-349 mg/ml iodine concentration, per ml |
Q9963 |
Hocm 350-399mg/ml iodine,1ml |
High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml |
Q9964 |
Hocm>= 400mg/ml iodine, 1ml |
High osmolar contrast material, 400 or greater mg/ml iodine concentration, per ml |
Q9965 |
Locm 100-199mg/ml iodine,1ml |
Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml |
Q9966 |
Locm 200-299mg/ml iodine,1ml |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
Q9967 |
Locm 300-399mg/ml iodine,1ml |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
Q9968 |
Visualization adjunct |
Injection, non-radioactive, non-contrast, visualization adjunct (e.g., methylene blue, isosulfan blue), 1 mg |
Q9969 |
Non-heu tc-99m add-on/dose |
Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose |
Q9970 |
Inj ferric carboxymaltos 1mg |
Injection, ferric carboxymaltose, 1mg |
Q9972 |
Epoetin beta esrd use |
Injection, epoetin beta, 1 microgram, (for esrd on dialysis) |
Q9973 |
Epoetin beta non esrd |
Injection, epoetin beta, 1 microgram, (non-esrd use) |
Q9974 |
Morphine epidural/intratheca |
Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg |
Q9975 |
Factor viii fc fusion recomb |
Injection, factor viii fc fusion protein (recombinant), per iu |
Q9976 |
Inj ferric pyrophosphate cit |
Injection, ferric pyrophosphate citrate solution, 0.1 mg of iron |
Q9977 |
Compounded drug noc |
Compounded drug, not otherwise classified |
Q9978 |
Netupitant palonosetron oral |
Netupitant 300 mg and palonosetron 0.5 mg |
Q9979 |
Injection, alemtuzumab |
Injection, alemtuzumab, 1 mg |
Q9980 |
Genvisc, inj, 1mg |
Hyaluronan or derivative, genvisc 850, for intra-articular injection, 1 mg |
Q9981 |
Rolapitant, oral, 1mg |
Rolapitant, oral, 1 mg |
Q9982 |
Flutemetamol f18 diagnostic |
Flutemetamol f18, diagnostic, per study dose, up to 5 millicuries |
Q9983 |
Florbetaben f18 diagnostic |
Florbetaben f18, diagnostic, per study dose, up to 8.1 millicuries |
Q9984 |
Kyleena, 19.5 mg |
Levonorgestrel-releasing intrauterine contraceptive system (kyleena), 19.5 mg |
Q9985 |
Inj hydroxyprogst capoat nos |
Injection, hydroxyprogesterone caproate, not otherwise specified, 10 mg |
Q9986 |
Makena, 10 mg |
Injection, hydroxyprogesterone caproate, (makena), 10 mg |
Q9987 |
Pathogen test for platelets |
Pathogen(s) test for platelets |
Q9988 |
Platelets, pathogen reduced |
Platelets, pheresis, pathogen-reduced, each unit |
Q9989 |
Ustekinumab, iv inject,1 mg |
Ustekinumab, for intravenous injection, 1 mg |
Q9991 |
Buprenorph xr 100 mg or less |
Injection, buprenorphine extended-release (sublocade), less than or equal to 100 mg |
Q9992 |
Buprenorphine xr over 100 mg |
Injection, buprenorphine extended-release (sublocade), greater than 100 mg |
Q9993 |
Inj., triamcinolone ext rel |
Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg |
Q9994 |
Enzyme cartridge enteral nut |
In-line cartridge containing digestive enzyme(s) for enteral feeding, each |
Q9995 |
Inj., emicizumab-kxwh 0.5 mg |
Injection, emicizumab-kxwh, 0.5 mg |